# Picolensing as a Probe of Primordial Black Hole Dark Matter

Preprint · Michael A. Fedderke, Sergey Sibiryakov

- Archive id: arxiv:2411.12947
- Published: 2024-11-20
- Venue: Phys. Rev. D 111, 063060 (2025)
- DOI: https://doi.org/10.1103/physrevd.111.063060
- arXiv: https://arxiv.org/abs/2411.12947
- Source URL: https://arxiv.org/abs/2411.12947
- PDF: https://arxiv.org/pdf/2411.12947
- Provenance: arxiv

## Abstract

The gravitational-lensing parallax of gamma-ray bursts (GRBs) is an intriguing probe of primordial black hole (PBH) dark matter in the asteroid-mass window, $2\\times 10^{-16}M\_{\\odot} \\lesssim M\_{\\text{PBH}} \\lesssim 5 \\times 10^{-12}M\_{\\odot}$. Recent work in the literature has shown exciting potential reach for this "picolensing" signal if a future space mission were to fly two x-/$γ$-ray detectors in the Swift/BAT class, with inter-spacecraft separation baselines on the order of the Earth-Moon distance. We revisit these projections with a view to understanding their robustness to various uncertainties related to GRBs. Most importantly, we investigate the impact of uncertainties in observed GRB angular sizes on reach projections for a future mission. Overall, we confirm that picolensing shows great promise to explore the asteroid-mass window; however, we find that previous studies may have been too optimistic with regard to the baselines required. Detector baselines on the order of at least the Earth-L2 distance would make such a mission more robust to GRB size uncertainties; baselines on the order of an astronomical unit (AU) would additionally enable reach that equals or exceeds existing microlensing constraints up to $M\_{\\text{PBH}} \\sim 2 \\times 10^{-8} M\_{\\odot}$.

_Abstract reproduced under CC0-1.0 (arXiv descriptive metadata)._

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.